News
OMS721 receives orphan designation for use in HSCT
- Author:
- HT Staff
The European Commission has granted orphan designation to OMS721 for use in the setting of hematopoietic stem cell transplant (HSCT). OMS721 is a...
News
NICE says CAR T-cell therapy isn’t cost-effective
- Author:
- HT Staff
The National Institute for Health and Care Excellence (NICE) has issued a draft guidance recommending against the use of axicabtagene ciloleucel (...
News
Lots of blood collection system recalled
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has announced a recall of 10 lots of the Leukotrap RC System with RC2D Filter, a blood collection system...
News
EC approves CAR T-cell therapy for DLBCL, PMBCL
- Author:
- HT Staff
The European Commission (EC) has approved the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (Yescarta®) to treat two...
News
EC approves product for high-risk AML
- Author:
- HT Staff
The European Commission (EC) has approved CPX-351 (Vyxeos), a liposomal formulation that delivers a fixed ratio of daunorubicin and cytarabine (44...
News
FDA grants fast track designation to CX-01 for AML
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted fast track designation to CX-01 as a treatment for patients older than 60 receiving...
News
EC approves CAR T-cell therapy for ALL, DLBCL
- Author:
- HT Staff
The European Commission (EC) has granted approval for tisagenlecleucel (Kymriah®), a chimeric antigen receptor (CAR) T-cell therapy targeting CD19...
News
FDA approves new use for ibrutinib in WM
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has approved ibrutinib (Imbruvica®) for use in combination with rituximab to treat adults with...
News
Rivaroxaban doesn’t reduce risk of fatal VTE
- Author:
- HT Staff
MUNICH—Extended thromboprophylaxis with rivaroxaban does not significantly reduce the risk of fatal venous thromboembolism (VTE) in patients...
News
Regimen appears effective in elderly, unfit MDS/AML
- Author:
- HT Staff
A low-intensity regimen could be an effective treatment option for elderly or unfit patients with newly diagnosed acute myeloid leukemia (AML) or...
News
Study reveals ‘complete mental health’ among cancer survivors
- Author:
- HT Staff
New research suggests cancer survivors are just as likely as people without a history of cancer to have complete mental health (CMH), which is...
News
Drug receives priority review for second MM indication
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for elotuzumab (...
News
D-dimer and WCP can render VDUs unnecessary
- Author:
- HT Staff
Venous duplex ultrasounds (VDUs) may be over-utilized in patients suspected of having deep vein thrombosis (DVT), according to research published...
News
Enzymes convert blood from type A to O more efficiently
- Author:
- HT Staff
BOSTON—New research suggests enzymes from the human gut can turn type A blood into type O more efficiently than previously studied enzymes....
News
AMP publishes report on DNA variants in CMNs
- Author:
- HT Staff
A new report addresses the clinical relevance of DNA variants in chronic myeloid neoplasms (CMNs). The report is intended to aid clinical...